MindMaze Therapeutics Holding SA (SWX:MMTX)
0.1992
+0.0012 (0.61%)
Jul 31, 2026, 5:30 PM CET
SWX:MMTX Balance Sheet
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 12.5 | 15.08 | 14.56 | 19.24 | 44.76 | 38.06 |
Cash & Short-Term Investments | 12.5 | 15.08 | 14.56 | 19.24 | 44.76 | 38.06 |
Cash Growth | 16.52% | 3.60% | -24.33% | -57.02% | 17.60% | 29404.65% |
Accounts Receivable | 0.58 | 1.44 | 1.17 | 1.32 | 1.3 | - |
Inventory | 0.92 | 1.04 | 0.56 | 0.23 | 0.39 | - |
Other Current Assets | 1.19 | 2.13 | 2.02 | 1.8 | 8.52 | 8.79 |
Total Current Assets | 15.19 | 18.38 | 18.3 | 22.58 | 54.97 | 46.85 |
Net Property, Plant & Equipment | 2.11 | 2.4 | 2.97 | 2.69 | 2.54 | - |
Other Intangible Assets | 30.58 | 31.03 | 54.41 | 162.92 | 192.3 | 30.8 |
Long-Term Investments | - | - | - | - | - | 0.39 |
Other Long-Term Assets | 0.11 | 0.12 | 0.71 | 0.61 | 1.81 | - |
Total Assets | 47.99 | 53.22 | 76.39 | 188.8 | 251.62 | 78.05 |
Liabilities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Accounts Payable | 0.62 | 1.63 | 1.03 | 1.63 | 1.7 | 1.43 |
Accrued Expenses | - | 1.99 | 6.2 | 7.91 | 19.47 | - |
Short-Term Debt | - | - | 1.7 | 1.65 | 1.35 | 0.89 |
Current Portion of Leases | 0.37 | 0.48 | 0.52 | 0.44 | 0.33 | - |
Unearned Revenue | 0.24 | 0.46 | - | - | - | - |
Other Current Liabilities | 2.53 | 2.42 | 3.43 | 3.9 | 4.27 | 4.37 |
Total Current Liabilities | 3.75 | 4.98 | 6.92 | 10.72 | 19.73 | 6.69 |
Long-Term Debt | - | - | - | 0.02 | 0.4 | - |
Long-Term Leases | 1.53 | 1.66 | 2.09 | 2.23 | 2.19 | - |
Other Long-Term Liabilities | 10.07 | 7.93 | 9.19 | 25.6 | 40.38 | 4.31 |
Total Long-Term Liabilities | 11.6 | 11.58 | 17.24 | 32.67 | 50.36 | 4.31 |
Total Liabilities | 15.35 | 16.56 | 24.16 | 43.38 | 70.09 | 11 |
Shareholders' Equity
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Common Stock | 1.41 | 1.4 | 56.16 | 56.16 | 44.13 | 32.47 |
Treasury Stock | -0.15 | -0.15 | -6 | -12.11 | -3 | - |
Additional Paid-in Capital | 271.6 | 271.15 | 220.33 | 220.96 | 210.15 | 69.77 |
Retained Earnings | -240.22 | -235.74 | -218.26 | -119.6 | -69.75 | -35.2 |
Shareholders' Equity | 32.63 | 36.66 | 52.23 | 145.42 | 181.53 | 67.04 |
Total Liabilities & Equity | 47.99 | 53.22 | 76.39 | 188.8 | 251.62 | 78.05 |
Additional Metrics
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Total Debt | 1.9 | 2.14 | 4.31 | 4.34 | 4.26 | 0.89 |
Net Cash (Debt) | 10.6 | 12.94 | 10.25 | 14.89 | 40.5 | 37.17 |
Net Cash Growth | 27.54% | 26.28% | -31.21% | -63.22% | 8.95% | - |
Net Cash Per Share | 0.84 | 1.03 | 0.87 | 1.41 | 0.01 | 0.01 |
Book Value | 32.63 | 36.66 | 52.23 | 145.42 | 181.53 | 67.04 |
Book Value Per Share | 2.60 | 2.92 | 4.44 | 13.76 | 0.05 | 0.03 |
Tangible Book Value | 2.06 | 5.64 | -2.19 | -17.5 | -10.77 | 36.24 |
Tangible Book Value Per Share | 0.16 | 0.45 | -0.19 | -1.66 | -0.00 | 0.02 |